[Federal Register Volume 84, Number 207 (Friday, October 25, 2019)]
[Notices]
[Pages 57435-57437]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-23366]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-20-1158; Docket No. CDC-2019-0095]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies the opportunity to comment on a proposed and/or 
continuing information collection, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on a proposed 
information collection project titled CDC Ideation Catalyst (I-
Catalyst) Program and Customer Engagement Information Collection. CDC 
will collect qualitative information from potential customers and other 
stakeholders about their needs and preferred approaches to solving 
public health problems. Findings will be used to improve customer 
satisfaction with, and usability of, CDC's products, programs, and 
services.

DATES: CDC must receive written comments on or before December 24, 
2019.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2019-
0095 by any of the following methods:
     Federal eRulemaking Portal: Regulations.gov. Follow the 
instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS-D74, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without

[[Page 57436]]

change, all relevant comments to Regulations.gov.
    Please note: Submit all comments through the Federal eRulemaking 
portal (regulations.gov) or by U.S. mail to the address listed above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: 
[email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected; and
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses.
    5. Assess information collection costs.

Proposed Project

    CDC Ideation Catalyst (I-Catalyst) Program and Customer Engagement 
Information Collection (OMB Control No. 0920-1158, Exp. 1/31/2020)--
Revision--Office of Science (OS), Centers for Disease Control and 
Prevention (CDC).

Background and Brief Description

    The CDC Office of Technology and Innovation (OTI) within Office of 
Science (OS) fosters innovative science and promotes the testing and 
implementation of innovative ideas that improve CDC's ability to have 
public health impact. To arm CDC staff with an expanded skill-set and 
tools to evaluate and translate their insights and ideas into 
solutions, CDC developed an experiential innovation curriculum called 
Ideation Catalyst (I-Catalyst). The program was created with the belief 
that innovation should be customer-driven, be based on user research, 
and is something people at all levels of an organization can engage in. 
CDC also obtained OMB approval for a generic clearance to support the 
collection of information from stakeholders and customers, utilizing I-
Catalyst program principles and methodology (CDC I-Catalyst Program, 
OMB Control No. 0920-1158, Exp. date 1/31/2020).
    The goal of the I-Catalyst program is to help CDC employees test 
and explore their ideas through a discovery, ideation, and prototyping 
process. I-Catalyst offers a process for defining problems and 
developing strategies to solutions that will help improve the quality 
and efficiency of innovation efforts and, as a result, overall 
performance. Through the I-Catalyst Program, teams work to define and 
articulate their problem space to find effective solutions and CDC 
programs receive consultation from OTI staff to implement the I-
Catalyst process with specific projects. Participating teams will go 
through a hypothesis-testing, scientific method of discovery to gather 
important insights and identify issues associated with their projects. 
Teams are forced ``out of the classroom'' to conduct interviews, study 
customer/stakeholder needs, collect feedback, and find partnership 
opportunities. It is expected that participants will gain the ability 
to evaluate and translate their insights into solutions.
    The I-Catalyst process provides CDC staff with real-world, hands-on 
entrepreneurship training and consultation from OTI staff. Through I-
Catalyst, CDC staff make hypotheses about how the world works, and then 
test them by getting out of the building and talking to customers and/
or stakeholders. Only conversations with potential customers/
stakeholders can provide the facts from which hypotheses are proven or 
disproven about whether a solution (whether a product, process, etc.) 
creates value for the intended beneficiaries. Participants have to go 
out into the world and learn by doing. I-Catalyst methods engage 
customers/stakeholders in a process that will identify what they most 
value and need, and source solutions that will have high levels of 
efficacy and user acceptability.
    The majority of data will be obtained through on-site, unstructured 
interviews with individuals who represent the customers or stakeholders 
CDC teams are attempting to serve or benefit. CDC may also collect 
information through telephone interviews, questionnaires, or web-based 
surveys. With each CDC program project, teams will interview their 
customers/stakeholders with a burden per response ranging from 20-60 
minutes (an average of 30 minutes). Each team will interview 
approximately 25 respondents. With 10-20 teams participating annually 
and CDC program consultations, approximately 500 respondents will be 
interviewed. Data to be collected includes information regarding needs, 
values, and barriers, and facilitators to potential solutions.
    CDC expects that teams participating in the I-Catalyst process and 
OTI consultations will be empowered to implement innovative strategies 
and solutions that create value for a set of beneficiaries. The 
ultimate goal is to give CDC staff skills to successfully transfer 
knowledge into value-based solutions that benefit society and broaden 
the agency's impact.
    In this Revision request, CDC seeks approval for minor changes to 
the I-Catalyst generic clearance. The number of burden hours will 
decrease based on participation in the I-Catalyst training program 
during the period 2017-2019. However, through related technical 
assistance provided by OTI to CDC/ATSDR programs, CDC has identified 
additional opportunities for information collection compatible with I-
Catalyst goals and methods. During the next three-year period CDC 
anticipates utilization of the I-Catalyst generic clearance by previous 
participants in the I-Catalyst training program, as well as other CDC 
programs implementing customer discovery projects. The title of the 
clearance is being updated to reflect its use by additional CDC/ATSDR 
project teams approved by OTI. The I-Catalyst clearance will continue 
to be used for information collections necessary to explore the needs 
and preferences of specific stakeholder groups, and to facilitate and 
improve the acceptance and usability of CDC products, programs, and 
technologies. All projects submitted to OMB for approval under the I-
Catalyst generic

[[Page 57437]]

clearance will be consistent with CDC/OTI goals for promoting 
scientific innovation, customer engagement, and entrepreneurship in 
public health.
    OMB approval is requested for three years. Individual projects must 
be approved by CDC's OTI before they are submitted to OMB for final 
review and approval. CDC estimates the estimated annual burden hours to 
be 250. Participation is voluntary, and there are no costs to 
respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of      Avg. burden
      Type of respondents           Form name        Number of     responses per   per response    Total burden
                                                    respondents     respondent       (in hrs.)       (in hrs.)
----------------------------------------------------------------------------------------------------------------
External Partners,              Interview                    500               1           30/60             250
 Stakeholders, or Customers.     Guides,
                                 Questionnaires,
                                 and Surveys.
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............             250
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2019-23366 Filed 10-24-19; 8:45 am]
 BILLING CODE 4163-18-P